Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
69.94B | 69.23B | 65.45B | 58.76B | 52.15B | 49.91B | Gross Profit |
10.62B | 10.68B | 10.04B | 10.57B | 9.63B | 5.66B | EBIT |
4.82B | 4.80B | 4.27B | 5.83B | 5.75B | -805.00M | EBITDA |
9.32B | 8.83B | 7.50B | 8.07B | 7.65B | 2.07B | Net Income Common Stockholders |
4.43B | 4.23B | 3.79B | 4.25B | 4.21B | -1.17B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
17.98B | 19.18B | 18.83B | 18.25B | 16.43B | 16.52B | Total Assets |
132.40B | 129.21B | 118.87B | 115.94B | 107.05B | 110.09B | Total Debt |
11.21B | 11.28B | 13.59B | 10.98B | 13.46B | 15.62B | Net Debt |
-2.46B | -3.73B | -2.88B | -4.84B | -1.11B | 1.18B | Total Liabilities |
110.31B | 109.52B | 101.14B | 102.96B | 97.56B | 103.64B | Stockholders Equity |
22.00B | 19.61B | 17.70B | 12.95B | 9.47B | 6.45B |
Cash Flow | Free Cash Flow | ||||
5.45B | 3.73B | 3.35B | 3.82B | 2.71B | -7.18B | Operating Cash Flow |
9.22B | 7.40B | 6.41B | 6.29B | 4.64B | -5.42B | Investing Cash Flow |
-6.48B | -6.65B | -4.13B | -3.11B | -2.72B | 4.13B | Financing Cash Flow |
-2.58B | -2.57B | -1.28B | -2.12B | -2.18B | 6.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | €51.32B | 49.51 | 14.05% | 1.14% | 11.66% | 3.13% | |
75 Outperform | €23.27B | 25.31 | 15.30% | 1.58% | 29.86% | 37.44% | |
74 Outperform | $129.74B | 29.22 | 21.75% | 1.81% | 5.16% | 12.89% | |
70 Outperform | €108.48B | 62.44 | -6.13% | 1.11% | 17.19% | -119.44% | |
66 Neutral | $4.51B | 12.29 | 5.40% | 3.67% | 4.15% | -12.21% |